Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopy

Christophe Sandt1, Olivier Feraud2, Marie-Laure Bonnet2

  • 1SOLEIL Synchrotron, Saint Aubin, 91192, Gif sur Yvette, France.

Insights

Fourier transform infrared (FTIR) microspectroscopy rapidly identifies the T315I mutation in chronic myeloid leukemia (CML) cells. This technique offers a new tool for early detection and drug screening of resistant CML.

Area of Science:

  • Biomedical Spectroscopy
  • Oncology
  • Molecular Biology

Background:

  • Tyrosine kinase inhibitors (TKI) are successful in treating chronic myeloid leukemia (CML).
  • Therapy resistance in CML can arise from mutations in the BCR-ABL oncogene's ABL-kinase domain.
  • The T315I mutation, a "gatekeeper" mutation, confers resistance to most TKIs, except Ponatinib.

Purpose of the Study:

  • To investigate Fourier transform infrared (FTIR) microspectroscopy as a method for identifying the T315I mutation in BCR-ABL.
  • To explore the potential of FTIR microspectroscopy for early detection and drug screening in CML.

Main Methods:

  • Utilized Fourier transform infrared (FTIR) microspectroscopy for single-cell analysis.
  • Employed Dox-inducible T315I-mutated BCR-ABL-expressing human UT-7 cells and murine embryonic stem cells for validation.
  • Performed transcriptome analysis to identify molecular signatures associated with the T315I mutation.

Main Results:

  • FTIR microspectroscopy successfully identified a unique spectral signature in single cells expressing the T315I-mutated BCR-ABL.
  • The specificity of the spectral signature was confirmed in engineered cell lines.
  • Transcriptome analysis revealed molecular differences linked to metabolic changes underlying the observed spectral signature.

Conclusions:

  • FTIR microspectroscopy is a powerful tool for rapid, single-cell identification of the T315I BCR-ABL mutation.
  • This methodology holds promise as a novel early detection tool for CML mutant clones.
  • The technique can potentially be applied to drug screening strategies targeting T315I-mutated CML cells.

Related Concept Videos

Mutations01:39

Mutations

Overview
94.5K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K